A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

HealthDay News — Multicancer early detection (MCED) tests can increase earlier-stage diagnoses and reduce late-stage diagnoses, according to a study published online Nov. 10 in Cancer.

There was no significant difference in survival outcomes for patients with advanced neuroendocrine tumors who were treated with low-dose everolimus compared to standard-dose everolimus, according to a ...

Researchers explored whether a direct-to-patient digital intervention could increase the number of lung cancer screening CTs among patients in 2 US health systems.

Findings showed both zanidatamab treatment arms demonstrated statistically significant and clinically meaningful improvements in PFS vs the SOC arm.

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Researchers presented efficacy and ongoing safety data from MonumenTAL-1, a phase 1/2 study assessing talquetamab in patients with multiple myeloma.

To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

The researchers found that the risk for depression was higher among breast cancer survivors than controls (hazard ratio, 5.94). Insomnia (defined as ≥8 on the Insomnia Severity Index) further ...

Study researchers noted that the findings suggest the association between anxiety and improved OS was at least partly related to the higher incidence of irAEs, which implies that, in people with an ...

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.

Investigators presented initial results from the phase 3 RAMPART trial of adjuvant durvalumab monotherapy or combined with tremelimumab for resected primary renal cell carcinoma.